Drug improves weight, A1C in patients with or without diabetes

11/11/2013 | MedPage Today (free registration)

Data on obese and overweight patients with or without diabetes showed those who took the weight-loss drug Qsymia shed more pounds at 56 weeks on either low or high doses of the drug compared with a placebo group. Diabetes patients who took the drug attained a mean A1C decline of 1.6%, compared with only 1.2% in the placebo arm, researchers reported at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID